BGS stock news
This page provides real-time market news, earnings updates, and company announcements related to B&G Foods, Inc. (BGS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 03:42 EST
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:33:55
GAT Guns Delivers Standout Results at Factory Shoot 2026 with Champion Safe
Finviz2026-03-23 12:09:51
Alchemy Investments Acquisition Corp. 1 Announces Evaluation of Potential Private Investment in Public Equity to Support Business Combination Transaction with Cartiga
Finviz2026-03-24 12:57:45
Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials
Finviz2026-03-25 11:03:54
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
Finviz2026-03-25 11:03:53
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
Finviz2026-03-25 20:03:47
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-26 20:03:51
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-26 20:09:55
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
Finviz2026-03-27 14:03:46
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 12:03:47
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn's Disease
Finviz2026-03-30 20:06:12
Innventure Reports Fourth Quarter and Full Year 2025 Results
Finviz2026-03-30 20:18:42
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:54:50
Binah Capital Group Reports Results for Fourth Quarter and Full Year 2025
Finviz2026-03-31 21:34:01
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
Finviz2026-04-01 13:03:53
Beyond Burger and Beyond Steak Become 1st Plant-Based Meat Products to Qualify as Climate Solutions
Finviz2026-04-02 13:06:50
TowneBank Announces Sale of Resort Property Management Segment
Finviz2026-04-06 12:33:04
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Finviz2026-04-09 12:03:52
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
Genco Shipping & Trading Issues Statement Regarding Diana Shipping's Letter to Shareholders
Finviz2026-04-13 21:27:13
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
Finviz2026-04-14 13:03:53
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
Finviz2026-03-25 11:03:53
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
Finviz2026-03-25 20:03:47
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-26 20:03:51
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-26 20:09:55
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
Finviz2026-03-27 14:03:46
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 12:03:47
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn's Disease
Finviz2026-03-30 20:06:12
Innventure Reports Fourth Quarter and Full Year 2025 Results
Finviz2026-03-30 20:18:42
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:54:50
Binah Capital Group Reports Results for Fourth Quarter and Full Year 2025
Finviz2026-03-31 21:34:01
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
Finviz2026-04-01 13:03:53
Beyond Burger and Beyond Steak Become 1st Plant-Based Meat Products to Qualify as Climate Solutions
Finviz2026-04-02 13:06:50
TowneBank Announces Sale of Resort Property Management Segment
Finviz2026-04-06 12:33:04
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Finviz2026-04-09 12:03:52
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
Genco Shipping & Trading Issues Statement Regarding Diana Shipping's Letter to Shareholders
Finviz2026-04-13 21:27:13
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
Finviz2026-04-14 13:03:53
BGS stock chart
BGS stock detailsBGS stock price change
On the last trading day, BGS stock closed at 5.53 USD, with a price change of -0.72% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more